Potassium-transporting ATPase subunit alpha gastric (ATP4A) (ATP4A)

The Potassium-transporting ATPase subunit alpha gastric, encoded by the ATP4A gene, is the catalytic subunit of the gastric H+/K+ ATPase, commonly known as the proton pump (UniProt P20648). Located in the apical membrane of parietal cells in the stomach lining, this enzyme is responsible for the final step of gastric acid secretion by exchanging cytoplasmic hydronium ions for extracellular potassium ions (NCBI Gene ID 495). This process is ATP-dependent and creates a massive pH gradient between the cytoplasm and the stomach lumen. Dysregulation or overactivity of this pump is a primary driver in acid-related disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers (StatPearls: Proton Pump Inhibitors). Pharmacological targeting of this enzyme is a cornerstone of gastroenterology, primarily through proton pump inhibitors (PPIs) which covalently bind to the subunit to inhibit acid production (PubMed: 29070309). Newer agents, known as potassium-competitive acid blockers (P-CABs), offer a reversible and faster-acting alternative by competing for the potassium-binding site (PubMed: 30102150). Chronic inhibition of this target can lead to physiological changes such as hypergastrinemia and altered nutrient absorption.

Other names

Gastric H+/K+ ATPase alpha subunitH(+)/K(+) ATPase alpha subunitProton pumpGastric hydrogen potassium ATPaseATP4A

Proton pump inhibitors (PPIs) act as prodrugs that undergo acid-catalyzed conversion to active sulfenamides, which then form covalent disulfide bonds with cysteine residues on the alpha subunit, leading to irreversible inhibition (StatPearls: Proton Pump Inhibitors). Potassium-competitive acid blockers (P-CABs) inhibit the enzyme by binding reversibly to the potassium-binding site in an ionic manner, providing a more rapid onset of action (PubMed: 30102150).